[1
]
From the Department for Anaesthesiology and Critical Care Medicine, Franziskus Hospital
Bielefeld and Hannover Medical School, Hannover, Germany (N.R.-M.); Biostatistics,
MSD-Oss, Oss, The Netherlands (H.F., M.S.); Division of Hematology and Thromboembolism,
Department of Medicine, McMaster University, and Thrombosis and Atherosclerosis Research
Institute, Hamilton, Ontario, Canada (S.S.); Anesthesiology and Intensive Care, Medical
Research Society, Danube Hospital, Vienna, Austria (W.K.); Department of Anesthesia
and Intensive Care, Annastift, Hannover, Germany (M.P.); Klinik für Anästhesiologie
der Technischen Universität München, Munich, Germany (M.B.); Klinik für Anästhesie
und Intensivtherapie, Universitätsklinikum, Marburg, Germany (H.W.); Global Scientific
and Medical Publications, Merck & Co., Inc., Whitehouse Station, New Jersey (C.M.S.);
and Clinical Research, Merck & Co., Inc., Whitehouse Station, New Jersey (D.W.-H.,
T.W., A.S.).